Table 2.
Characteristic | Cefazolin (n = 45) | Nafcillin/Oxacillin (n = 34) | P Value |
---|---|---|---|
Hospital length of stay, d | 9 [5.5–15.5] | 13 [6–25] | .52 |
Treatment failure at week 6 | |||
Antibiotic extension due to clinical failure | 34 (75.6) | 28 (82.4) | .58 |
Epidural abscess–related death | 2 (4) | 2 (5.9) | 1 |
Treatment failure at week 12 | |||
Antibiotic extension due to clinical failure | 15 (33.3) | 15 (44.1) | .35 |
Epidural abscess–related death | 0 | 0 | 1 |
Mortality | 7 (15.6) | 4 (11.8) | .75 |
Overall, d | 290 [38–1301] | 114 [11.75–1348] | .52 |
Overall at 6 wk | 2 (4.4) | 2 (5.9) | 1 |
30-d mortality | 1 (2) | 2 (5.9) | .57 |
90-d mortality | 0 | 0 | 1 |
90-d recurrence | 5 (11.4) | 3 (9.4) | 1 |
Treatment interruption due to adverse drug event | 1 (2) | 1 (2.9) | 1 |
Data are presented as No. (%) or median [interquartile range].